Armata Pharmaceuticals, Inc. (ARMP)
Data as of , from SEC Form 4 filings.
See up to 3 months of ARMP. The 7-day demo opens the 1M and 3M ranges and puts ARMP on your watchlist.
Start 7-day demoLatest ARMP insider trades
About Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. is an SEC registrant, filing under CIK 0000921114, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
ARMP Form 4 activity by transaction type, last 90 days
No Form 4 activity for ARMP in the last 90 days.
ARMP insider transactions (Form 4)
1515 Form 4 filings on record, the earliest from Oct 3, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Deborah Birx - Officer | Tax withholding / forfeiture | Common Stock | 14,041 footnote F1 | $4.26 | $60K | |
| ||||||
| Daniel B. Gilmer - Director | Grant or award | Stock Options (Right to Buy) | 51,280 | $0.00 | - | |
| Pierre Kyme - Officer | Tax withholding / forfeiture | Common Stock | 1,030 footnote F1 | $10.54 | $11K | |
| ||||||
| Deborah Birx - Officer | Tax withholding / forfeiture | Common Stock | 4,919 footnote F1 | $10.54 | $52K | |
| ||||||
| Robin Kramer - Director | Grant or award | Stock Options (Right to Buy) | 25,640 | $0.00 | - | |
| Pierre Kyme - Officer | Grant or award | Stock Options (Right to Buy) | 183,142 | $0.00 | - | |
| David Duane House - Officer | Grant or award | Stock Options (Right to Buy) | 109,885 | $0.00 | - | |
| Joseph M. Patti - Director | Grant or award | Stock Options (Right to Buy) | 25,640 | $0.00 | - | |
| Todd C. Peterson - Director | Grant or award | Stock Options (Right to Buy) | 25,640 | $0.00 | - | |
| Kostas D. Odysseas - Director | Grant or award | Stock Options (Right to Buy) | 25,640 | $0.00 | - | |
| Deborah Birx - Officer | Grant or award | Stock Options (Right to Buy) | 421,226 | $0.00 | - | |
 Sarah J. Schlesinger - Director | Grant or award | Stock Options (Right to Buy) | 25,640 | $0.00 | - | |
| Jules Haimovitz - Director | Grant or award | Stock Options (Right to Buy) | 25,640 | $0.00 | - | |
| Deborah Birx - Officer | Tax withholding / forfeiture | Common Stock | 13,637 | $2.27 | $31K | |
| David Duane House - Officer | Grant or award | Stock Options (Right to Buy) | 75,000 | $0.00 | - | |
ARMP insider trading FAQ
What is the latest insider trade for ARMP?
Armata Pharmaceuticals, Inc. (ARMP) has filed no insider reports in the last 90 days. The most recent on record is dated 14 July 2026. The full record for ARMP runs to 15 Form 4 filings, the earliest from 3 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ARMP stock?
No insider purchases of ARMP were filed in the last 90 days.
How many insiders are selling ARMP stock?
No insider sales of ARMP were filed in the last 90 days.
Where can I see ARMP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ARMP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Deborah Birx view on EDGAR
- - Daniel B. Gilmer view on EDGAR
- - Pierre Kyme view on EDGAR
- - Deborah Birx view on EDGAR
- - Robin Kramer view on EDGAR
- - Pierre Kyme view on EDGAR
- - David Duane House view on EDGAR
- - Joseph M. Patti view on EDGAR
- - Todd C. Peterson view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ARMP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ARMP with a 7-day demo
- ARMP on your watchlist
- Every ARMP Form 4 filing on record
- Up to 3 months of ARMP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
